Utah Code 49-20-417. Insurance coverage for amino acid-based formula
Current as of: 2023 | Check for updates
|
Other versions
49-20-417. Insurance coverage for amino acid-based formula.
(1) | As used in this section:
|
(2) | Beginning plan year 2017-18 and ending plan year 2019-20, the Public Employees’ Benefit and Insurance Program shall offer a 3-year pilot program within the state risk pool that provides coverage for the use of an amino acid-based elemental formula, regardless of the delivery method of the formula, for the diagnosis or treatment of an eosinophilic gastrointestinal disorder, food protein-induced enterocolitis syndrome, severe protein allergic condition, or short bowel syndrome in the traditional and Star plans. |
(3) | Coverage offered under Subsection (2) applies to an amino acid-based elemental formula if:
|
(4) | Coverage offered under Subsection (2) may not include cost-sharing provisions, including deductibles, copayments, co-insurance, and out-of-pocket limits, or a durational limit, that are less favorable to the insured than the cost-sharing provisions and durational limits applied by the health benefit plan to prescription drugs. |
(5) | The purpose of the program is to study the efficacy of providing coverage for the use of an amino acid-based elemental formula and is not a mandate for coverage of an amino acid-based elemental formula within the health plans offered by the Public Employees’ Benefit and Insurance Program. |
(6) | Under Section 63J-1-603 of the Utah Code, the Legislature intends that the cost of the program shall be paid for from funds above the minimum recommended level in the public employees’ state risk pool reserve. |
Enacted by Chapter 349, 2017 General Session
Technically renumbered to avoid duplication of section number also enacted in HB154, Chapter 241.